RIT Capital Partners’s Panacea Acquisition Corp. II Class A Ordinary Shares PANA Stock Holding History

RIT Capital Partners’s Portfolio PANA Stock Details PANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-900,000	Closed	-$9.18M	–	15
2023 Q1	$9.18M	Hold	900,000	–	–	2.78%	10
2022 Q4	$9.04M	Hold	900,000	–	–	3.6%	8
2022 Q3	$8.82M	Hold	900,000	–	–	51.96%	1
2022 Q2	$8.78M	Hold	900,000	–	–	6.43%	6
2022 Q1	$8.77M	Hold	900,000	–	–	3.64%	6
2021 Q4	$8.72M	Hold	900,000	–	–	3.09%	8
2021 Q3	$8.78M	Hold	900,000	–	–	3.42%	7
2021 Q2	$9M	Buy	+900,000	New	+$9.01M	3.04%	8

RIT Capital Partners's PANA Position: Q2 2023 in Review

RIT Capital Partners sold out of Panacea Acquisition Corp. II Class A Ordinary Shares (PANA) in Q2 2023, closing a stake of 900,000 shares — an estimated $9.18M sold.

RIT Capital Partners first reported a position in PANA in Q2 2021 and held it in 8 quarters. The position peaked at $9.18M in Q1 2023. 0 funds tracked by Wall St. Rank hold PANA as of Q2 2023.

RIT Capital Partners reported no remaining Panacea Acquisition Corp. II Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
RIT Capital Partners sold 900,000 Panacea Acquisition Corp. II Class A Ordinary Shares shares in Q2 2023, an estimated $9.18M.
RIT Capital Partners first reported a position in Panacea Acquisition Corp. II Class A Ordinary Shares in Q2 2021 and held it in 8 quarters.
RIT Capital Partners's Panacea Acquisition Corp. II Class A Ordinary Shares position peaked at $9.18M in Q1 2023.
0 funds tracked by Wall St. Rank held Panacea Acquisition Corp. II Class A Ordinary Shares as of Q2 2023.

Based on RIT Capital Partners's 13F filing for Q2 2023, filed 11 Aug 2023.